Anti-c-Myc (Phospho-T58) Antibody 
Datasheet
MSDS
Description: Rabbit polyclonal antibody to c-Myc (Phospho-T58) Immunogen: KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding T58 of human c-Myc protein. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography. Clonality: Polyclonal Form: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. Dilution: WB (1/500 - 1/1000), IH (1/100 - 1/200), IP (1/10 - 1/100) Gene Symbol: MYC Alternative Names: BHLHE39; Myc proto-oncogene protein; Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64Entrez Gene (Human): 4609Entrez Gene (Mouse) : 17869Entrez Gene (Rat) : 24577SwissProt (Human): P01106SwissProt (Mouse) : P01108SwissProt (Rat) : P09416Storage/Stability : Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of c-Myc (Phospho-T58) expression in mouse brain (A), mouse lung (B) whole cell lysates. -
Immunohistochemical analysis of c-Myc (Phospho-T58) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma
Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer